Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study

The aim of the study was to evaluate efficacy and tolerance of epirubicin and gemcitabine as first-line chemotherapy in patients with advanced non-small-cell lung cancer. A phase I study was performed with the combination of escalating doses of epirubicin intravenously on day 1 and a fixed dose of g...

Descripción completa

Detalles Bibliográficos
Autores principales: van Putten, J W G, Eppinga, P, Erjavec, Z, de Leede, G, Nabers, J, Smeets, J B E, Sleijfer, D Th, Groen, H J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374380/
https://www.ncbi.nlm.nih.gov/pubmed/10732750
http://dx.doi.org/10.1054/bjoc.1999.1003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374380/
https://www.ncbi.nlm.nih.gov/pubmed/10732750
http://dx.doi.org/10.1054/bjoc.1999.1003

Ejemplares similares